Abstract. The adhesive and signaling functions of integrins are regulated through their cytoplasmic domains. We identified a novel 111 residue polypeptide, designated 133-endonexin, that interacted with the cytoplasmic tail of the ~3 integrin subunit in a yeast two-hybrid system. This interaction is structurally specific, since it was reduced by 64% by a point mutation in the 133 cytoplasmic tail ($752----~P) that disrupts integrin signaling. Moreover, this interaction is integrin subunit specific since it was not observed with the cytoplasmic tails of the eqlb, {31, or 132 subunits. 133-Endonexin fusion proteins bound selectively to detergent-solubilized 133 from platelets and human umbilical vein endothelial cells, and 133-endonexin mRNA and protein were detected in platelets and other tissues. A related mRNA encoded a larger polypeptide that failed to bind to 13 integrin tails. The apparent specificity of 133-endonexin for the 133 integrin subunit suggests potential mechanisms for selective modulation of integrin functions.
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HESION receptors of the integrin superfamily are heterodimers composed of et and [3 type I transmembrane subunits (40) . Each subunit consists of a relatively large extracellular domain that participates in ligand binding, a single transmembrane domain, and a short cytoplasmic tail that in most cases contains 20-70 amino acids. The 133 integrins include O~1ib133 , which is specific for the megakaryocytic lineage, and etv [33, which is also expressed on endothelial cells, vascular smooth muscle cells, monocytes, macrophages, osteoclasts, and certain subpopulations of lymphocytes (7, 17, 20, 57, 66) . ~IIb133 and 0tv133 recognize several Arg-Gly-Asp-containing adhesive ligands in a divalent cation-dependent manner and these interactions are crucial for hemostasis, wound healing and angiogenesis (28, 63) .
In addition to their adhesive functions, it is now apparent that integrins interact with the intracellular signaling machinery of cells. The affinity or avidity of many integrins for their cognate ligands is regulated by cellular agonists and antagonists in a process called inside-out signaling. For example, eqib [33 in platelets is converted to a high affinity state following cellular activation, and this process can be prevented or reversed by compounds that increase platelet adenylyl cyclase or guanylyl cyclase (63) . Affinity modulation may be controlled through an interaction of intracellular signaling molecules with integrin cytoplasmic tails, since deletions or mutations of the tails exert profound effects on receptor affinity and cell adhesion (37, 42, 53, 65) .
Integrins also function to transduce extracellular cues into the cell, a process called outside-in signaling. In this case, adhesive ligands induce receptor clustering, activation of protein tyrosine kinases, such as pp125 FAK, dramatic rearrangements of the actin cytoskeleton, and changes in gene expression that affect cell growth, differentiation and programmed death (8, 12, 41) . As is the case with inside-out signaling, integrin cytoplasmic tails may play a significant role. Several studies have begun to identify proteins that bind to integrin cytoplasmic tails in vitro. For example, calreticulin binds to a-tails (48) , and a-actinin, talin and pp125 FAK bind to 13 tails (39, 54) (Otey, C. A., Schaller, M., and Parsons, J. T. 1993. Mol. Biol. Cell 4:347a). The functional relevance of these interactions in vivo remains to be defined. Nonetheless, given the strong circumstantial evidence that 13 cytoplasmic tails modulate integrin function, the present study was carried out to identify direct, binary interactions between a prototypic 13 tail (133) and intracel-lular proteins. We describe here a novel polypeptide named 133-endonexin, initially identified using a yeast two-hybrid approach (18, 31) , that interacts with the 133 integrin cytoplasmic tail in a structurally specific manner.
Materials and Methods

DNA Constructions
The cytoplasmic tails of the integrin subunits studied are shown in Table I . These tails were amplified from existing pCDM8 expression constructs (15, 53) using sense primers containing BamHI or EcoRl restriction sites and antisense primers containing PstI or BamHI sites. Gel-purified PCR products were digested with the appropriate restriction enzymes and directionally cloned into the yeast expression vector, pGBT9 (Clontech Laboratories, Inc., Palo Alto, CA) (6) . This resulted in the in-frame fusion of each cytoplasmic tail to the 3' end of the GAL4(,_147) DNA-binding domain. All DNA sequences were confirmed by sequencing both strands, either with Sequenase Version 2.0 (7-deaza-dGTP kit; US Biochemical Corp., Cleveland, OH) or by automated sequencing in the Scripps Research Institute DNA Core Facility.
Library Screening
A human cDNA library in a lambda vector (hACT) was derived from EBV-transformed peripheral blood B lymphocytes and was the kind gift of Stephen Elledge (Baylor College of Medicine, Houston, TX). This library, containing 3 × 106 independent clones, had been ligated into the vector at a XhoI site, resulting in fusion to the 3' end of the GAL4(768_883) activation domain (25, 27) . Before use, hACT was converted from phage h to plasmid DNA (pACT) (27) .
To screen for proteins that bind to the 133 cytoplasmic tail, the yeast two-hybrid system was employed as described by Fields and co-workers (6, 18, 30, 31 (61) . Transformants were grown for three days at 30°C on agar plates containing SD synthetic media without tryptophan. Then a colony was selected and grown overnight in 5 ml of SD without tryptophan to seed a 1 litre culture in YPD medium, which was grown to a density of OD600 = 0.3. Cells were made competent in 30 ml of 0.1 M LiAc and TE (1 mM EDTA and 0.01 M Tris-Hcl, pH 7.5) and then transformed by adding 250 Ixg of pACT/B cell library DNA, 1 mg of denatured salmon sperm DNA (Oncor, Inc., Gaithersburg, MD), and 140 ml of LiAc/TE containing 40% PEG 4000 (Sigma Chemical Co., St. Louis, MO). After 30 min at 22°C, DMSO was added to a final concentration of 10% (vol/vol), the cells were heat-shocked for 6 min at 42°C, and then washed and resuspended in 10 ml of TE. 100 ~1 aliquots were plated in 100 × 15 mm plastic petri dishes containing SD agar with 25 mM 3-aminotriazole but no tryptophan, leucine or histidine. Transformants were grown for 8 d at 30°C. The Y190 host strain contains two reporter genes, HIS3 and lacZ, under the control of GALA. In principle, these genes should be transactivated by library fusion proteins that interact with the 133 integrin cytoplasmic tail to reconstitute functional GALA.
13-Galactosidase activity of individual colonies was determined qualitatively in a filter-lift assay (10) . Positive colonies were restreaked on SD plates lacking leucine and tryptophan and retested. Positives were grown overnight in 5 ml SD without leucine and plasmid DNA was obtained (38) , and used to transform competent HB101 cells by heat shock according to the supplier's protocol (GIBCO BRL, Gaithersburg, MD). Transformants were grown at 37°C for 1-2 d on M9 minimal agar without leucine in the presence of 50 ixg/ml ampiciUin. Colonies containing library DNA inserts were identified by digestion with XhoI and the DNA was purified by CsC12 ultracentrifugation (59) . DNA was then re-introduced into yeast to confirm transactivation of HIS3 and lacZ and to exclude false positives. Two additional expression constructs (Clontech) were used to exclude false positive reactions: pLAM 5', which encodes a human lamin C/GAL4 DNA-binding domain hybrid in pGBT9, and pTD1, which encodes an SV-40 large T-antigen/GAL4 activation domain hybrid in pGAD3F. As described in Results, this selection process yielded a "true positive" clone (No. 28) which was then characterized in detail.
Cloning of Full-length cDNAs
Sequence analyses of the 719-bp clone 28 insert suggested it was a partial cDNA clone. To obtain the 5' end of the cDNA, a human testes 5'-RACE-ready cDNA library (Clontech) was subjected to two-step 5'-RACE PCR (26) . The first reaction contained 2 p.l of template cDNA, an anchor sense primer (5'-CTGGTTCGGCCCACCTCTGAAGGTFC-CAGAATCGATAG-3'), and a clone 28-specific antisense primer (5'-TAGACATGCACCTGCCAACTGCTACGAG-3') in a final vol of 50 i~1. The second reaction contained 2 O.1 of a 1:10 dilution of the primary PCR product, the anchor primer and a nested clone 28-specific antisense primer (5'-CATTATCTCCATGA'ITICTTCTGAC-3'). Reactions were "hot started" followed by incubation for 5 min at 94°C, 30 PCR cycles (62°C for 1 min; 72°C for 2.5 min; 94°C for 1 min), and a final 5-rain incubation at 72°C. A 600-bp PCR product was gel-purified, subcloned into pCR (Invitrogen, San Diego, CA) and sequenced on both strands.
To identify potential alternate forms of clone 28-related mRNA, the B-cell cDNA library in pACT was subjected to PCR using clone 28-specific primers (sense: 5'-GTAGTATACAGTGACAAAAGTG-3'; antisense: 5'-TAGACATGCACCTGCCAACTGCTACGAG-3'). Hot-start reactions used 50 ng of cDNA, 50 pmol of each primer and 5 U of Taq polymerase (Boehringer-Mannheim Biochemicals, Indianapolis, IN) in 50 ~1 for 30 cycles (55°C for 1.5 min; 72°C for 2.5 min; 94°C for 1 min). After a final incubation for 5 min at 72°C, 5 ixl were electrophoresed on a 2.5% agarose gel and stained with ethidium bromide. PCR products were subcloned into pCR and sequenced.
Comparative Binding Studies of lntegrin Cytoplasmic Tails
The two-hybrid system was also used to quantify the extent of binary interactions between clone 28-related polypeptides and the integrin cytoplasmic tails shown in Table I . After simultaneous transformation of Y190 with 5 Ixg of pGBT9/integrin tail DNA and 5 p.g of pACT/clone 28 DNA, transformants were grown on SD agar without tryptophan and leucine. After 3 d, four independent colonies from each transformation were picked and grown overnight at 30°C in 3 ml of SD media without tryptophan and leucine. Then 0.5 ml of each were processed for quantitation of 13-galactosidase activity, which was expressed in units (6) . The results were taken as a measure of the strength of the interaction between a given integrin tail and clone 28-related polypeptides.
To examine interactions between the polypeptide expressed by clone 28 and a natural 133 or 131 subunit in vitro, the polypeptide was expressed as a GST fusion protein. PCR was used to introduce 5' BamHI and 3' XhoI restriction sites at either end of a 285-bp putative coding region in clone 28. The PCR product was digested, ligated into these sites in pGEX-5X-1 (Pharmacia Biotech, Inc., Piscataway, NJ), and then used to transform DH5ct. DNA sequencing confirmed that the clone 28 insert was now fused in-frame to GST at a factor Xa recognition site. The mass of HPLC-puri- fled GST/clone 28 fusion protein as determined by electrospray mass spectrometry was that expected for the authentic protein (observed = 37,323 _+ 2.7 D; calculated average isotopic composition = 37,322.9 D). Additional bacteria were transformed with pGEX-5X-1 as a source of GST.
Glutathione Sepharose affinity matrices, containing either GST/clone 28 fusion protein or GST alone, were prepared as described by Frangione and Neel (34) . Preliminary immunoblotting experiments with an anti-GST antiserum (Pharmacia) showed that approximately equal amounts of fusion protein or GST had bound to the matrix. Human platelets and human umbilical vein endothelial cells (passage 3) were used as sources of 133. Platelets were washed (64) and resuspended to 2 × 109 cells/ml in a lysis buffer containing 1% Triton X-100, 0.05 M Tris, pH 7.4, 1 mM PMSF, 0.5 mM leupeptin, 100 U/ml aprotinin, and either 1 mM CaClz to maintain the alibi33 complex or 1 mM EDTA to dissociate it (9). After 30 min at 22°C, the detergent-soluble fraction was obtained by centrifugation at 14,000 rpm for 30 min at 4°C. The detergent-soluble fraction of sub-confluent endothelial cells was obtained in the same manner. After pre-equilibration of the glutathione Sepharose affinity matrices in lysis buffer, platelet or endothelial cell lysates were diluted eightfold in lysis buffer with inhibitors and 0.5 ml aliquots were added to 100 ~1 batches of affinity matrix for 12 h at 4°C with gentle shaking. The matrices were then washed with 10 bed volumes of lysis buffer and proteins were eluted by boiling for 5 min in 30 ~L1 of SDS sample buffer under non-reducing conditions (46) . 20 p.l of each sample were electrophoresed in 7.5% SDS-polyacrylamide gels (46) , transferred to a 0.45 ~m nitrocellulose membrane (Millipore Corp., Bedford, MA) (68) , and immunoblotted with a monoclonal antibody specific for 133 (SSA6, 10 Ixg/ml) (1), a goat antiserum against human 131 (1:500; a gift from Martin Hemler, Dana Farber Cancer Institute, Boston, MA), or a monoclonal antibody against P-selectin (S12, 10 ixg/ml; a gift from Rodger McEver, Oklahoma Medical Research Foundation, Oklahoma City, OK) (51). Immunoreactivity was determined using affinity-isolated, peroxidase-conjugated goat anti-rabbit Ig (1:3,000) (Tago, Inc., Burlingame, CA) and the ECL chemiluminescence reaction (Amersham Corp., Arlington Heights, IL) (36) .
To examine interactions between natural 131 and 133 integrin subunits and 133-endonexin, the latter polypeptide was bacterially-expressed with a histidine (6) tag fused to the amino terminus (pET His Tag System; Novagen, Inc, Madison, WI). The protein was purified by HPLC and its mass verifed by mass spectometry. An affinity matrix was prepared by binding 2 mg of his-tagged 133-endonexin to 1.5 ml of His Bind metal chelation resin according to the supplier's instructions (Novagen). After washing with platelet lysis buffer, 2 ml of platelet lysate (6.6 mg protein) was incubated with the matrix for 1 h at 4°C. The matrix was then loaded into a column and washed with lysis buffer (twice with 2 ml, and then thrice with 3 ml), and then eluted with 2 ml of a buffer containing 200 mM imidazole, 0.5 M NaCI, 20 mM Tris-HCl, pH 7.9. Samples were analyzed by SDS-PAGE on 4-20% gels and by immunoblotting as described in the legend to Fig. 7 .
Detection of Clone 28-related mRNAs in Cells and Tissues
Northern blots were performed using a Human MTN Blot II (Clontech) as a source of poly A ÷ RNA according to the supplier's instructions. The 719-bp insert from clone 28 was obtained by XhoI digestion, labeled with (a-a2p)dATP using a commercial kit (Prime-It II Random Primer Labeling Kit; Stratagene, La Jolla, CA), and used as a probe.
Primer extension reactions were carried out to confirm the 5' ends of mRNAs encoding clone 28-related proteins (59) . First strand cDNA synthesis was accomplished using washed platelets as a source of total RNA and either of two clone 28-specific antisense oligonucleotides that had been 5'-labeled with 32p (5'-AACCCAGCAACTTCCGAAAACAGAAA-ATCCGCC-3' or 5'-CAGAAAATCCGCCAAAGGAAACCACGAAT-TCAC-3'). Control studies showed that no PCR product was obtained when first strand synthesis was omitted.
Several human cDNA libraries as well as reverse-transcribed platelet mRNA were subjected to PCR as described above to screen for the presence of a reaction product specific for 133-endonexin. The primers are described in the legend to Fig. 4 B. The following libraries were examined: B cell in pACT, and placenta and brain in pGAD424 (the latter two from Clontech).
Detection of Proteins
Expression of GAL4 DNA-binding domain fusion proteins containing either the anb, 132, or 133 tails was confirmed by immunoblotting with rabbit antisera (1:500) specific for these tails (53) . Individual yeast transformants were grown overnight at 30°C in 5 ml of SD without tryptophan. Cells were washed, resuspended in SDS sample buffer containing I mM PMSF, 0.5 mM leupeptin and 100 KIU/ml aprotinin, and lysed by vortexing for 30 s × 3 in the presence of 0.5 vol of 500 I~ acid-washed glass beads (Sigma) and then boiling for 10 min. Supernatants were analyzed for protein content (BCA; Pierce Chemical Co., Rockford, IL) and 35 fxg aliquots were electrophoresed under non-reducing conditions and immunoblotted as described above.
133-Endonexin expression was analyzed in fresh human platelets and in a mononuclear fraction of peripheral blood leukocytes (5) by immunoblotting. Cells were washed and lysed for 10 min in boiling SDS sample buffer containing 5 mM EDTA, 0.5 mM leupeptin, 4 mM Pefabloc (Boehringer-Mannheim), 10 ixg/ml pepstatin A (Sigma), and 2 mM N-methyl maleimide. Platelet and mononuclear leukocyte lysates (40 ~xg/lane) were electrophoresed under reducing conditions, and transferred to nitrocellulose (Schleicher & Schuell, Keene, NH) as described (36) , except that the transfer solution was buffered with CAPS, pH 11. Blots were probed with two different rabbit antisera (1:1000) reactive with 133-endonexin. The first (antiserum 0834) was obtained using a thyroglobulin-conjugated synthetic peptide consisting of the predicted carboxy-terminal 17 residues of 133-endonexin. The second (antiserum 0835) was raised against the GST/ clone 28 fusion protein described above. Both antisera reacted on immunoblots with this fusion protein, with clone 28 polypeptide obtained by factor Xa cleavage of the fusion protein, and with His-tagged 133-endonexin; neither antibody reacted with GST.
Results
Detection of a Polypeptide That Binds to the Cytoplasmic Tail of the Integrin l]3 Subunit
A yeast two-hybrid system was used to screen for proteins that interact with the 133 cytoplasmic tail. Nucleotides encoding the entire 47-amino acid cytoplasmic tail of 133 (Ta- (Fig. 1 A) . However, fusion protein expression did not cause transactivation of the two GALA reporter genes present in the yeast host strain (HIS3 and lacZ) . Therefore, the [33 tail was used as a ligand to screen for binding partners in an EBV-transformed B lymphocyte cDNA library which had been fused to the DNA activation domain of GAL4 (25, 27) . Of 1.7 million co-transformants plated, 90 colonies grew in the absence of histidine. Seven also expressed ~-galactosidase activity in a filter-lift assay, suggesting that a library-derived fusion protein was interacting with the [33 cytoplasmic tail. Five of these colonies contained an identical 719-bp library insert and were considered to be "true positives". Their plasmid D N A caused transactivation of HIS3 and lacZ when reintroduced into yeast expressing the [33 cytoplasmic tail, but no such activation was observed in yeast expressing an unrelated fusion protein (lamin C). Fig. 2 shows the results of quantitative [3-galactosidase assays for one of the positive clones (No. 28), which was subsequently characterized in detail.
To determine whether the polypeptide expressed by clone 28 could interact with the [33 cytoplasmic tail in a context outside of yeast, the cloned D N A insert was sequenced and a 285-bp coding region was identified. This sequence was used to construct and express the corresponding 95-amino acid polypeptide as a soluble GST fusion protein. When the fusion protein was attached0to a glutathione Sepharose matrix and incubated with a dotergent extract from platelets (a source rich in OtlIb [33) , the ~3 Figure 3 . Specific interaction in vitro between the polypeptide expressed by clone 28 as a GST fusion protein and the 133 integrin subunit. As described in Materials and Methods, affinity matrices were prepared containing either GST or GST fused to the 95-amino acid polypeptide expressed by clone 28. Platelet lysate was then incubated with the matrices for 12 h at 4°C, followed by SDS-PAGE and immunoblotting of bound proteins with monoclonal antibodies specific for 133 (A) or P-selectin (B). As positive immunoblot controls, lanes 1 and 4 were loaded with 20 t~g of platelet lysate. Lanes 1-3 represent platelet lysate prepared in the presence of 1 mM EDTA, while lanes 4--6 represent lysate prepared with 1 mM CaCI2. This experiment is representative of three so performed.
subunit was retained by the affinity matrix. In contrast, another highly expressed platelet protein, P-selectin, was not retained by this matrix, nor was [33 retained by a control GST matrix (Fig. 3) . The retention of [33 on the clone 28 affinity matrix was observed independent of whether platelets had been solubilized in the presence of 1 mM 
Alternate Forms of Clone 28-related mRNA Encode Polypeptides That Bind Differentially to the f13 Cytoplasmic Tail
The 719-bp library insert from clone 28 was used to probe Northern blots of eight human tissues. A band of reactivity was observed at approximately 1.1 kb in all tissues, with greatest reactivity in testes and colon (Fig. 4 A) . In an attempt to obtain full-length cDNA clones representing this mRNA, 5'-RACE PCR was performed using a testes cDNA library as template. To complement this analysis, PCR reactions were carried out using the original B lymphocyte cDNA library as a template and clone 28-specific oligonucleotides as primers. With this combined approach, the 5'-untranslated and coding regions and most of the 3'-untranslated region were characterized, and two closely related mRNAs were identified: a "shorter" form containing 897 bp and a "longer" form containing 1041 bp (Fig. 4  B) . The apparent transcription start site for both mRNAs at residue 1 in Fig. 5 A was confirmed by primer extension analysis of platelet m R N A (not shown). A putative start 
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3 and 5'-CTCGTAGCAGTTGGCAGGTGCATGTCTA-3', respectively. As shown on the bottom, the predicted 265-bp 133-endonexin PCR product was observed when B cell, placenta and brain cDNA libraries and reverse-transcribed platelet mRNA were used as templates. As controls, this band was also observed when 133-endonexin in pACT was used as a template, but not when pACT/Clone 28 Long was used.
codon at bases 131-133 is in a suitable environment for translation initiation (44) , and it is in-frame with downstream sequences that encode the clone 28 fusion protein identified in the two-hybrid screen. A n open reading frame for the shorter m R N A species would encode a 111 amino acid, 12.6-kD polypeptide. The carboxy-terminal 90 amino acids are identical to corresponding amino acids in clone 28. The longer m R N A species differs from the shorter one due to insertions of 93 and 50 bp, as indicated Figure 5 . Sequences of clone 28-related cDNAs. Panel A shows the nucleotide sequence and deduced amino acid sequence of cDNA derived from the longer of the two clone 28-related mRNAs described in the text. A start codon is at nucleotides 131-133. The shaded areas show which nucleotides and amino acids are deleted to form the shorter mRNA and its deduced polypeptide (133-endonexin). The circled alanine is encoded by a GCT in the longer mRNA but this is replaced by a stop codon in 133-endonexin. B compares these mRNAs diagrammatically. The coding region for 133-endonexin is represented by the shaded rectangle (nucleotides 131-463), and the dark rectangle in the longer mRNA represents nucleotides encoding an additional 59 amino acids. These sequence data are available from EMBL/GenBank/ DDBJ under accession number U37139.
in Fig. 5 A. In this case, the open reading frame would encode a 170 amino acid, 19.2-kD polypeptide that differs from the shorter polypeptide due to an additional 59 amino acids at the carboxy terminus (Fig. 5 B) .
The capacity of these two different clone 28-related m R N A s to express polypeptides that bind to the 133 cytoplasmic tail was tested in the two-hybrid system. The shorter i l l -a m i n o acid polypeptide bound to the 133 cytoplasmic tail as well as the original clone 28 fusion protein (Fig. 6) . In light of its ability to bind to a portion of an integrin subunit normally located inside the cell, the polypeptide was named [33-endonexin (from the roots, "endon" or within, and "nexus" or connection). In contrast, the 170-amino acid polypeptide, hereafter referred to simply as "clone 28-long", failed to bind to the 133 tail (Fig. 6 ). Not shown is the fact that the longer polypeptide also failed to bind to the cytoplasmic tails of the 131 or 132 integrin subunits. ~3-Endonexin nucleotide sequences were not represented in either GenBank or EMBL nucleotide databases as of May 18, 1995 . Searches of these databases through the National Center for Biotechnology Information using either the BLASTN (3) or FASTN (56) algorithms failed to disclose complete identities. A 395-bp expressed sequence tag derived from mouse testis (MUSBO48A) exhibited 78% identity over a 232-nucleotide stretch. Other than this, no other similarities were identified. Thus, 133-endonexin is a novel protein.
The 111-amino acid 133-endonexin sequence was analyzed with the University of Wisconsin Genetics Computer group package (23) . This polypeptide has a predicted molecular mass of 12,624 and a predicted pI of 8.3. Its amino acid composition is unremarkable, being comprised of 31% charged and 23% hydrophobic residues. The presence of a single cysteine suggests that the mature protein could contain a free sulfhydryl group. The protein contains 17 Ser and 9 Thr residues suggesting that it may be subject to modification by phosphorylation or glycosylation. Indeed, Ser 28 is in an appropriate context for phosphorylation by protein kinase A (29, 35) , and Ser 6, Thr 24, and Thr 79 are in contexts favorable for protein kinase C (72) . Analysis of hydrophilicity (45), averaged over a window of seven residues, revealed no long hydrophobic stretches consistent with the absence of both a signal peptide and transmembrane domains. Consequently, [33-endonexin is predicted to be an intracellular protein.
Searches of non-redundant protein sequence databases through the National Center for Biotechnology Information using BLAST (3) and FASTA (56) revealed no homologies of obvious biological significance. Similarly, search of the PROSITE database with the MOTIFS program (23) failed to identify any rare sequence motifs within 133-endonexin.
Structural Specificity of the [33-endonexin/[33 Cytoplasmic Tail Interaction
There are several highly conserved regions in the cytoplasmic tails of most 13 integrin subunits (e.g., see Table I ) (60, 71) . Despite this, the [32 cytoplasmic tail did not interact with 133-endonexin in the yeast two-hybrid system. Moreover, a chimeric 133/[~1 cytoplasmic tail containing the membrane-proximal 11 residues of 133 and the distal 36 residues of ~1 bound minimally to 133-endonexin. Also, no interaction was observed between f33-endonexin and the cytoplasmic tail of tXnb (Fig. 6 ). This lack of interaction with integrin tails other than 133 was not likely to be due to insufficient expression of these tails in yeast. Expression of the eqi b and 132 fusion proteins was confirmed by immunoblotting with tail-specific antibodies (Fig. 1, B and C) . Altogether, these results indicate that 133-endonexin binds selectively to the 133 cytoplasmic tail, probably due to recognition of membrane-distal sequences unique to 133.
Further support for this conclusion was obtained by studying a point mutant of the 133 cytoplasmic tail, $752--4P (Table I) . In human platelets, this mutation is associated with a bleeding disorder due to defective agonist-induced activation of and fibrinogen binding to eqib~33 (14) . Moreover, CHO cells expressing this mutant exhibit markedly reduced spreading and focal adhesion formation following adhesion to fibrinogen (16) . When the $752----~P cytoplasmic tail was tested in the two-hybrid system, it showed a 64% reduction in binding to [33-endonexin compared to the wild-type 133 tail (P < 0.001) (Fig. 6 ).
To determine whether 133-endonexin exhibited a selective interaction with the 133 integrin subunit in vitro, a histidine-tagged form of 133-endonexin was expressed in bacteria and attached non-covalently to a metal chelation affinity resin. The 133 integrin subunit from a detergent extract of platelets was retained and eluted from this [33-endonexin affinity matrix, while the f31 integrin subunit from the same cells was not (Fig. 7) . Thus, studies in yeast and with recombinant 133-endonexin in vitro indicate that the binding of this polypeptide to the 133 integrin tail is structurally specific.
Tissue and Cellular Expression of fl3-Endonexin
In order to begin to assess the significance of 133-endonexin expression in cells, PCR of several cDNA libraries was carried out using oligonucleotides specific for 133-endonexin. A PCR product was detected in cDNA libraries from human brain, B lymphocytes and placenta as well as in cDNA obtained from platelets by RT-PCR (Fig. 4 B) . The product from B lymphocytes was cloned and sequenced and its identity to 133-endonexin was confirmed.
Next, platelets and a mononuclear fraction of peripheral blood leukocytes were examined by immunoblotting to Figure 7 . Specific interaction between recombinant 133-endonexin and the 133 integrin subunit. As described in Materials and Methods, an affinity matrix was prepared containing histidinetagged [33-endonexin bound non-covalently to a metal chelation resin. Platelet lysate (2 ml) was incubated with the affinity resin for 12 h at 4°C. After five washes, proteins were eluted from the resin in 2 ml of buffer containing 200 mM imidazole. Lysates (lane 1; 12 txg protein), initial flowthrough (lane 2; 15 p.l), first column wash (lane 3; 15 Ixl), and resin eluate (15 Ixl) were then subjected to SDS-PAGE under non-reducing conditions and the gel was stained with Coomassie blue (A) or transferred to nitrocellulose and immunoblotted with monoclonal antibodies specific for 133 (B) or 131 (C). Some proteins were present in the first wash but none were detectable in the fifth wash (not shown). Note in A that a number of proteins in the platelet lysate were depleted in the flow-through and eluted from the column with imidazole. Some of these proteins, one of which migrated identically with the 133 integrin subunit (upper arrow), may represent proteins that bind directly or indirectly to f33-endonexin. Two faster migrating bands (double arrows) represent monomeric and dimeric forms of recombinant f33-endonexin. Immunoblotting demonstrated that the [33 integrin subunit was relatively depleted from the flow-through and eluted from the resin (B), while the 131 integrin subunit was not. This experiment is representative of three so performed.
characterize 133-endonexin expression at the protein level. Using a rabbit anti-peptide antiserum specific for the putative carboxy terminus of 133-endonexin, an immunoreactive band migrating at approximately 13 kD was observed in platelets. This band was specific because it was not observed with pre-immune serum or when the immune serum had been pre-incubated with the immunizing peptide (Fig. 8) . The same band was observed using a different rabbit antiserum raised against a GST/clone 28 fusion protein. A specific band was also detected in blood mononuclear leukocytes using the anti-peptide antiserum (Fig. 8 ).
D i s c u s s i o n
In the present study, a human c D N A has been identified that encodes a novel 12.6 kD, 111-amino acid polypeptide that binds to the cytoplasmic tail of the 133 integrin subunit. was found in washed platelets by RT-PCR. Here again, however, the cellular origin of the mRNA is not entirely unambiguous since platelet preparations are always contaminated with some leukocytes. Since [33 integrin expression appears relatively restricted (e.g., endothelial cells, platelets, monocytes/macrophages, osteoclasts and certain lymphocyte subsets (7, 17, 20, 57, 66) , the apparent wide tissue distribution of [33- Integrins exhibit an intimate but poorly understood relationship with the signaling machinery of cells. In many cases, their affinity for adhesive ligands can be influenced by the state of cellular activation (24, 40) . Furthermore, integrin ligation and clustering can trigger biochemical reactions that affect the growth, differentiation and death programs of cells (8, 41, 52) . Implicit in these observations is a requirement for regulated interactions between integrins, cytoskeletal and cytoplasmic proteins. Accordingly, there is currently intense interest in identifying the components of integrin signaling pathways as well signaling elements that link these pathways to others that transfer information from the cell surface to the nucleus (22, 69) . Recent studies of a variety of cell types have begun to define such interactions (13, 19, 48, 55, 60, 62) . In one such study in fibroblasts (70) , immunoprecipitation was used to demonstrate that insulin stimulation promotes an association of av[33 and insulin receptor substrate-1, a protein that mediates insulin signaling by specifically binding to several intracellular targets. This interaction required the [33 subunit but not avOther studies have begun to map sites within the [3 cytoplasmic tails that are involved in interactions with specific intracellular proteins. For example, using synthetic peptides derived from integrin tails, Otey and co-workers have identified two discontinuous sequences within the [31 tail that bind c~-actinin (54) (53, 58) .
In contrast to the above studies, where more than one type of [3 subunit is involved in interactions with ot-actinin or FAK, we found that [33-endonexin bound only to the cytoplasmic tail of [33. The specificity of this interaction is underscored by the inability of the larger clone 28-related polypeptide to interact with the 133 tail (Fig. 6 ). Neither the [32 tail nor a chimeric tail made up of the membrane-proximal 11 residues of [33 and the distal 36 residues of [31 interacted with [33-endonexin. Since the sequences of the membrane-proximal portions of the three [3 subunits are very similar (Table I) , residues unique to the distal portion of the [33 tail must be responsible for binding. This notion is supported by two other observations. First, interaction of the 133 tail with [33-endonexin in the yeast system was markedly reduced when proline was substituted for serine at [33 residue 752 (Fig. 6) (63) . Of note in this context, [33 $752 appears critical for this process in both integrins. Platelets from individuals homozygous for the $752---~P mutation do not bind soluble fibrinogen due to defective agonist-induced conversion of Ctllb[33 to a high affinity state (14) . This same mutation abolishes Cqib[33-mediated spreading of CHO cells on fibrinogen (16) and etv[33-mediated clot retraction by melanoma cells (Chen, Y., and M. Ginsberg, unpublished observations). It is intriguing, therefore, that [33- endonexin binds at or near a region of the [33 tail that regu-lates both the adhesive and signaling functions of these integrins. Thus, this novel interaction or others like it could provide a structural context to explain how a cell might be able to regulate the function of one integrin despite the presence of multiple integrins. Furthermore, the ~3 integrins have been implicated in several pathological processes, including thrombosis, coronary restenosis after angioplasty, osteoporosis and tumor angiogenesis (11, 32, 50, 67). The present studies suggest that it might be possible to develop therapeutic strategies that target a specific integrin tail or proteins that bind differentially to that tail.
